122 related articles for article (PubMed ID: 12453673)
21. Apolipoprotein E and Alzheimer's disease: a genetic, molecular and neuroimaging review.
Swartz RH; Black SE; St George-Hyslop P
Can J Neurol Sci; 1999 May; 26(2):77-88. PubMed ID: 10352866
[TBL] [Abstract][Full Text] [Related]
22. Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer's disease.
Hayes JP; Logue MW; Sadeh N; Spielberg JM; Verfaellie M; Hayes SM; Reagan A; Salat DH; Wolf EJ; McGlinchey RE; Milberg WP; Stone A; Schichman SA; Miller MW
Brain; 2017 Mar; 140(3):813-825. PubMed ID: 28077398
[TBL] [Abstract][Full Text] [Related]
23. Investigations into geriatric psychiatry challenges: AAGP Senior Investigator Award 2000.
Small GW
Am J Geriatr Psychiatry; 2000; 8(4):276-83. PubMed ID: 11069266
[TBL] [Abstract][Full Text] [Related]
24. Use of positron emission tomography in diagnosing Alzheimer's disease.
J Neurosci Nurs; 1996 Aug; 28(4):275. PubMed ID: 8880604
[No Abstract] [Full Text] [Related]
25. Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients.
Lee KU; Lee JS; Kim KW; Jhoo JH; Lee DY; Yoon JC; Lee JH; Lee DS; Lee MC; Woo JI
J Neuropsychiatry Clin Neurosci; 2003; 15(1):78-83. PubMed ID: 12556576
[TBL] [Abstract][Full Text] [Related]
26. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR
Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113
[TBL] [Abstract][Full Text] [Related]
27. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers.
Lind J; Persson J; Ingvar M; Larsson A; Cruts M; Van Broeckhoven C; Adolfsson R; Bäckman L; Nilsson LG; Petersson KM; Nyberg L
Brain; 2006 May; 129(Pt 5):1240-8. PubMed ID: 16537568
[TBL] [Abstract][Full Text] [Related]
28. Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention.
Vanitallie TB
Metabolism; 2013 Jan; 62 Suppl 1():S30-3. PubMed ID: 23021038
[TBL] [Abstract][Full Text] [Related]
29. Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints.
Cavedo E; Chiesa PA; Houot M; Ferretti MT; Grothe MJ; Teipel SJ; Lista S; Habert MO; Potier MC; Dubois B; Hampel H; ;
Alzheimers Dement; 2018 Sep; 14(9):1204-1215. PubMed ID: 30201102
[TBL] [Abstract][Full Text] [Related]
30. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
[TBL] [Abstract][Full Text] [Related]
32. Can neuroimaging techniques identify individuals at risk of developing Alzheimer's disease?
Bottino CM; Almeida OP
Int Psychogeriatr; 1997 Dec; 9(4):389-403. PubMed ID: 9549589
[TBL] [Abstract][Full Text] [Related]
33. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.
Reiman EM; Caselli RJ; Yun LS; Chen K; Bandy D; Minoshima S; Thibodeau SN; Osborne D
N Engl J Med; 1996 Mar; 334(12):752-8. PubMed ID: 8592548
[TBL] [Abstract][Full Text] [Related]
34. APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease.
Reinvang I; Espeseth T; Westlye LT
Neurosci Biobehav Rev; 2013 Sep; 37(8):1322-35. PubMed ID: 23701948
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
[TBL] [Abstract][Full Text] [Related]
36. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
[TBL] [Abstract][Full Text] [Related]
37. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L
Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347
[TBL] [Abstract][Full Text] [Related]
38. Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.
Buckley RF; Mormino EC; Amariglio RE; Properzi MJ; Rabin JS; Lim YY; Papp KV; Jacobs HIL; Burnham S; Hanseeuw BJ; Doré V; Dobson A; Masters CL; Waller M; Rowe CC; Maruff P; Donohue MC; Rentz DM; Kirn D; Hedden T; Chhatwal J; Schultz AP; Johnson KA; Villemagne VL; Sperling RA; ; ;
Alzheimers Dement; 2018 Sep; 14(9):1193-1203. PubMed ID: 29803541
[TBL] [Abstract][Full Text] [Related]
39. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
40. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
Ossenkoppele R; Pijnenburg YA; Perry DC; Cohn-Sheehy BI; Scheltens NM; Vogel JW; Kramer JH; van der Vlies AE; La Joie R; Rosen HJ; van der Flier WM; Grinberg LT; Rozemuller AJ; Huang EJ; van Berckel BN; Miller BL; Barkhof F; Jagust WJ; Scheltens P; Seeley WW; Rabinovici GD
Brain; 2015 Sep; 138(Pt 9):2732-49. PubMed ID: 26141491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
